#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Ian Butterworth Email
Cofounder & CTO . Leuko
How to contact Ian Butterworth
Join and see Ian's contact info for free!Current Roles
Employees:
18Revenue:
$4.5MAbout
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.Leuko Address
8 St. Marys StreetBoston, MA
United States